Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xiaomei Huang, Suhua Zhang, Yanxia Ma, Heng Yang, Chuan He, Rufang Tian, Han Mei, Lipeng Liu & Bikui Zhang. (2019) Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles. Drug Design, Development and Therapy 13, pages 255-264.
Read now
Read now
Arpamas Seetasith, Mallik Greene, Ann Hartry & Chakkarin Burudpakdee. (2019) Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder. ClinicoEconomics and Outcomes Research 11, pages 741-755.
Read now
Read now
Ludovic Samalin, Aurore Tremey & Pierre-Michel Llorca. (2014) Quetiapine extended release for the treatment of bipolar disorder. Expert Review of Neurotherapeutics 14:9, pages 987-1005.
Read now
Read now
Max Schmauss, Vlado Jukić, Alberto Siracusano, Leszek Bidzan, George M. Badescu, Valentinas Maciulis, Marjolein Lahaye, Dagmar Hoeben, Christophe Tessier & Andreas Schreiner. (2012) Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study. Current Medical Research and Opinion 28:8, pages 1395-1404.
Read now
Read now
Articles from other publishers (11)
Matteo Lippi, Giuseppe Fanelli, Chiara Fabbri, Diana De Ronchi & Alessandro Serretti. (2022) The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?. International Clinical Psychopharmacology 37:6, pages 263-275.
Crossref
Crossref
Claudia Asenjo-Lobos, Carolina Fonseca, Stefan Leucht, Carles Garcia-Ribera & Marcela Cortés-Jofré. (2018) Clozapine versus quetiapine for people with schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Maria Azmanova, Anaïs Pitto-Barry & Nicolas P. E. Barry. (2018) Schizophrenia: synthetic strategies and recent advances in drug design. MedChemComm 9:5, pages 759-782.
Crossref
Crossref
Huafang Li, Niufan Gu, Hongyan Zhang, Gang Wang, Qingrong Tan, Fude Yang, Yuping Ning, Honggeng Zhang, Zheng Lu, Xiufeng Xu, Jianguo Shi, Chengge Gao, Lingjiang Li, Kerang Zhang, Hongjun Tian, Xiaoping Wang, Keqing Li, Huichun Li, Yi Xu, Shiping Xie & Xin Yu. (2016) Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial. Psychopharmacology 233:7, pages 1289-1297.
Crossref
Crossref
Pei-Yin Pan, Meei-Shyuan Lee & Chin-Bin Yeh. (2015) The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population. BMC Psychiatry 15:1.
Crossref
Crossref
Michael Riedel, Margot Schmitz, Peter Kåre Østergaard, Luigi Ferrannini, Manuel A. Franco, Vincenza Alfano & Eva Dencker Vansvik. (2015) Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: A randomised, double-blind, crossover study (eXtRa). Schizophrenia Research 162:1-3, pages 162-168.
Crossref
Crossref
H L Philpott, S Nandurkar, J Lubel & P R Gibson. (2014) Republished: Drug-induced gastrointestinal disorders. Postgraduate Medical Journal 90:1065, pages 411-419.
Crossref
Crossref
H L Philpott, S Nandurkar, J Lubel & P R Gibson. (2014) Drug-induced gastrointestinal disorders. Frontline Gastroenterology 5:1, pages 49-57.
Crossref
Crossref
Wei-Lieh Huang, Li-Ren Chang, Terry B.J. Kuo, Yu-Hsuan Lin, Ying-Zai Chen & Cheryl C.H. Yang. (2013) Impact of Antipsychotics and Anticholinergics on Autonomic Modulation in Patients With Schizophrenia. Journal of Clinical Psychopharmacology 33:2, pages 170-177.
Crossref
Crossref
Kalyn Hendrix & Ray Lorenz. (2012) Quetiapine in delusional parasitosis secondary to psychotic disorder: A case report. Mental Health Clinician 2:2, pages 41-42.
Crossref
Crossref
Cecilio Álamo & Francisco López-Muñoz. (2012) Eficacia de quetiapina de liberación prolongada en la sintomatología afectiva. Revista de Psiquiatría y Salud Mental 5, pages 3-19.
Crossref
Crossref